Background illustration for clinical trials search

Multiple Myeloma Clinical Trials

Browse 1,243 multiple myeloma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: St. John's, Moncton, Saint John, Quebec, Montreal,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06182774

Phase3, Recruiting

Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy

for
Hematologic Malignancy, Blood Cancer, Lymphoma, Leukemia,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05646576

Recruiting

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

for
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma,
Location: Jacksonville FL, Grand Forks ND
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05969860

Phase2, Recruiting

Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

for
Multiple Myeloma in Relapse
Location: New York NY
Sponsor: Larysa Sanchez

Sex: All

Age: 70+

Code: NCT06827860

Phase2, Recruiting

Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.

for
Refractory Multiple Myeloma
Location: West Hollywood CA
Sponsor: Oncotherapeutics

Sex: All

Age: 18+

Code: NCT04519476

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06485076

Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Weymouth MA, Boston MA, Brighton MA, Methuen MA,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT02269592

Recruiting

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

for
Multiple Myeloma, Smoldering, Multiple Myeloma,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06055894

Recruiting

VitD3 Supplementation in Patients With Multiple Myeloma

for
Multiple Myeloma
Location: Augusta GA
Sponsor: Amany Keruakous, MD, MS.

Sex: All

Age: 18+

Code: NCT05846880

Early_phase1, Recruiting

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

for
Amyloidosis, Basal Cell Carcinoma, Biliary Tract Carcinoma,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07285044

Phase2, Recruiting

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

for
Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18 - 70+

Code: NCT05976555

Phase1, Recruiting

Delayed Toxicities Post-CAR-T

for
Multiple Myeloma
Location: New York NY, San Francisco CA
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07665307

Recruiting

A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma (MM), Multiple Myeloma Refractory,
Location: Columbia MD, Nashville TN, Denver CO, Las Vegas NV,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT07637578

Phase2, Recruiting

A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Beverly Hills CA
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07589634

Phase2, Recruiting

A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma

for
Multiple Myeloma
Location: Atlanta GA, Denver CO
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06768489

Phase1, Recruiting

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Bethesda MD, Baton Rouge LA, Tacoma WA, Los Angeles CA
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07609940

Recruiting

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

for
Cytokine Release Syndrome, Recurrent Multiple Myeloma,
Location: Columbus OH
Sponsor: Naresh Bumma

Sex: All

Age: 18+

Code: NCT07657312

Phase2, Recruiting

Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07456605

Phase1, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Shirley NY, Farmington CT, Mineola NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

for
Multiple Myeloma
Location: Iowa City IA
Sponsor: Christopher Strouse

Sex: All

Age: 18+

Code: NCT07581704

Phase1, Recruiting